Phathom Pharmaceuticals (PHAT) Invested Capital (2018 - 2026)

Phathom Pharmaceuticals (PHAT) has reported Invested Capital for 3 consecutive years, with $10.3 million the latest figure, recorded in Q2 2021.

• In Q2 2021, Invested Capital rose 644.78% year-over-year to $10.3 million; the TTM figure through Mar 2022 stood at $10.3 million (down 60.31% YoY), while the FY2020 annual figure was $7.4 million, down 70.59% from the prior year.
• Invested Capital eased to $10.3 million in Q2 2021 per PHAT's latest filing, from $11.8 million in the prior quarter.
• Across five years, Invested Capital topped out at $50.0 million in Q1 2020 and bottomed at $1.4 million in Q2 2020.
• Historically, Invested Capital has averaged $17.1 million across 3 years, with a median of $11.1 million in 2021.
• Annual changes were most pronounced in 2020 — Invested Capital tumbled 77.78% — and 2021, when it jumped 644.78%.
• Phathom Pharmaceuticals' Invested Capital stood at $25.0 million in 2019, then plunged by 70.59% to $7.4 million in 2020, then jumped by 40.69% to $10.3 million in 2021.
• Business Quant data shows PHAT's Invested Capital at $10.3 million in Q2 2021, $11.8 million in Q1 2021, and $7.4 million in Q4 2020.